Basis of Presentation and Significant Accounting Policies - Additional Information (Details) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
| Summary Of Significant Accounting Policies [Line Items] | |||
| Common stock, par value | $ 0.001 | $ 0.001 | |
| Revenue | $ 0 | $ 64,521 | |
| Reverse stock split description | On June 30, 2023, we effected a reverse stock split at the ratio of 1 post-split share for every 6 pre-split shares. | ||
| Research and Development Expense | $ 2,751,279 | 2,854,119 | |
| Vendor [Member] | |||
| Summary Of Significant Accounting Policies [Line Items] | |||
| Research and Development Expense | 90,000 | $ 0 | |
| Payable balance to vendor | $ 109,000 | $ 57,000 | |
| Customer Concentration Risk | Sales Revenue | |||
| Summary Of Significant Accounting Policies [Line Items] | |||
| Concentration risk, percentage | 100.00% | ||
| X | ||||||||||
- Definition Research and development cost payable balance. No definition available.
|
| X | ||||||||||
- Definition Summary of significant accounting policies. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|